Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Aila Fakhimahmadi"'
Autor:
Aila Fakhimahmadi, Ilir Hasanaj, Gerlinde Hofstetter, Clara Pogner, Markus Gorfer, Markus Wiederstein, Nathalie Szepannek, Rodolfo Bianchini, Zdenek Dvorak, Sebastian A. Jensen, Markus Berger, Erika Jensen-Jarolim, Karin Hufnagl, Franziska Roth-Walter
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 15, p 11934 (2023)
Alternaria alternata is a common fungus strongly related with severe allergic asthma, with 80% of affected individuals being sensitized solely to its major allergen Alt a 1. Here, we assessed the function of Alt a 1 as an innate defense protein bindi
Externí odkaz:
https://doaj.org/article/1fa0fbe8577f4dcebc6188b06041a3c5
Autor:
Andreas Regner, Nathalie Szepannek, Markus Wiederstein, Aila Fakhimahmadi, Luis F. Paciosis, Bart R. Blokhuis, Frank A. Redegeld, Gerlinde Hofstetter, Zdenek Dvorak, Erika Jensen-Jarolim, Karin Hufnagl, Franziska Roth-Walter
Publikováno v:
Antioxidants, Vol 12, Iss 1, p 42 (2022)
Bet v 1 is the major allergen in birch pollen to which up to 95% of patients sensitized to birch respond. As a member of the pathogenesis-related PR 10 family, its natural function is implicated in plant defense, with a member of the PR10 family bein
Externí odkaz:
https://doaj.org/article/c5566021487845128f871ce7ed242c28
Autor:
Mahnaz Mohammadi Kian, Saeed Mohammadi, Atousa Haghi, Aila Fakhimahmadi, Mohsen Nikbakht, Ardeshir Ghavamzadeh, Mahdieh Salemi, Hassan Yousefi, Marveh Rahmati, Mohammad Amin Moosavi
Publikováno v:
IUBMB Life. 73:130-145
A little number of current autophagy inhibitors may have beneficial effects on the acute myeloid leukemia (AML) patients. However, there is a strong need to figure out which settings should be activated or inhibited in autophagy pathway to prevail dr
Autor:
Mahdieh Salemi, Aila Fakhimahmadi, Atousa Haghi, Ardeshir Ghavamzadeh, Mohsen Nikbakht, Hassan Yousefi, Saeed Mohammadi, Mahnaz Mohammadikian, Marveh Rahmati, Mohammad Amin Moosavi
Background : Few current autophagy inhibitors may have beneficial effects for acute myeloid leukemia (AML) patients in clinical phases. However, there is a strong need to figure out which settings should be activated or inhibited in autophagy pathway
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8226c89086f18cd1025f40822439a5d8
https://doi.org/10.21203/rs.3.rs-19050/v1
https://doi.org/10.21203/rs.3.rs-19050/v1
Autor:
Nazila Moghtaran Bonab, Aila Fakhimahmadi, Mohammad Amin Moosavi, Farinaz Nazmi, Marveh Rahmati, Mehrdad Hashemi
Publikováno v:
Leukemia Research. 63:15-21
Here, we report that targeting Nucleostemin (NS), a recently discovered stem cells-enriched gene, by a specific small interference RNA (siNS), decreases the rate of proliferation of acute promyelocytic leukemia (APL) NB4 cells and induces differentia